Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: A population-based study from Northern Italy

Clinical Cancer Research

Volumn 13, Issue 1, 2007, Pages 182-186

  Arcaini, Luca ^a   Burcheri, Sara ^a   Rossi, Andrea ^b   Pascutto, Cristiana ^a   Passamonti, Francesco ^a   Brusamolino, Ercole ^a   Paulli, Marco ^a   Orlandi, Ester ^a   Buelli, Maurizio ^b   Viero, Piera ^b   Lucioni, Marco ^a   Montanari, Francesca ^a   Merli, Michele ^a   Cortelazzo, Sergio ^b   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ORGAN DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; SECOND CANCER; SKIN CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GASTRIC MUCOSA; HUMANS; ITALY; LYMPHOMA, B-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846297681     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0703     Document Type: Article

References (23)

1. Travis LB, Curtis RE, Boice JD, Jr., et al. Second cancers following non-Hodgkin's lymphoma. Cancer 1991;67:2002-9.
2. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85:1932-7.
3. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 2005;4:8-15.
4. Calvert R, Randerson J, Evans P, et al. Genetic abnormalities during transition from Helicobacter pylori-associated gastritis to low-grade MALToma. Lancet 1995;345:26-7.
5. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-4.
6. Zucca E, Pinotti G, Roggero E, et al. High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol 1995;6:726-8.
7. Luppi M, Longo G, Ferrari MG, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996;94:373-5.
8. Au WY, Gascoyne RD, Le N, et al. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol 1999;10:317-21.
9. Montalban C, Castrillo JM, Lopez-Abente G, et al. Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma 1999;33:161-8.
10. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November, 1997. Hematol J 2000;1:53-66.
11. Clayton DHM. Statistical models in epidemiology. Oxford: Oxford University Press; 1993.
12. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
13. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
14. Witherell HL, Hansen S, Jellum E, et al. Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. J Infect Dis 1997;176:1641-4.
15. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA+ or CagA- Helicobacter pylori infection. Gut 1997;40:297-301.
16. Sakai T, Ogura Y, Narita J, et al. Simultaneous early adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 2003;6:191-6.
17. Levy V, Miller C, Koeffler HP, et al. p53 in lymphomas of mucosal-associated lymphoid tissues. Mod Pathol 1996;9:245-8.
18. Neumeister P, Hoefler G, Beham-Schmid C, et al. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology 1997;112:1871-5.
19. Shinmura K, Sugimura H, Naito Y, et al. Frequent co-occurrence of mutator phenotype in synchronous, independent multiple cancers of the stomach. Carcinogenesis 1995;16:2989-93.
20. Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003;101:2489-95.
21. Arcaini L, Burcheri S, Rossi A, et al. Nongastric marginal zone B-cell lymphoma of MALT: prognostic value of disease dissemination. Oncologist 2006;3:285-91.
22. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002;100:1989-96.
23. Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005;11:3349-52.